Goals To determine whether a less invasive method of aortic valve substitute (AVR) improves clinical final results Hesperadin in diabetics with aortic stenosis (Seeing that). for 1-calendar year all-cause mortality (p=0.048). Among diabetics all-cause mortality at 12 months was 18.0% in the transcatheter group and 27.4% in the surgical group (HR 0.60; 95% CI 0.36… Continue reading Goals To determine whether a less invasive method of aortic valve